CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN
The article presents the review of clinical studies that determined the role of apixaban in the early treatment and long-term secondary prophylaxis of deep vein thrombosis and lower limbs and and/or pulmonary arteries embolism. It also defines a patient population for whom apixaban administration is...
Saved in:
Main Author: | I. S. Yavelov (Author) |
---|---|
Format: | Book |
Published: |
«REMEDIUM GROUP» Ltd.,
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Apixaban role in the treatment of venous thromboembolic complications in patients with active cancer
by: E. P. Panchenko
Published: (2020) -
Clinical utility of apixaban in the prevention and treatment of venous thromboembolism: current evidence
by: Zalpour A, et al.
Published: (2014) -
Safety of discontinuation of anticoagulants after venous thromboembolism: whether D-dimer level should be taken into account?
by: I. S. Yavelov
Published: (2023) -
Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events
by: O. V. Shatalova
Published: (2015) -
Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events
by: O. V. Shatalova
Published: (2015)